Nektar Therapeutics financial data

Symbol
NKTR on Nasdaq
Industry
Pharmaceutical Preparations
Location
455 Mission Bay Boulevard South, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
INHALE THERAPEUTIC SYSTEMS INC (to 1/10/2003), INHALE THERAPEUTIC SYSTEMS (to 5/14/1998)
Latest financial report
10-K - Q4 2024 - Mar 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 487 % -37.3%
Quick Ratio 12.9 % -61.9%
Debt-to-equity 328 % +104%
Return On Equity -151 % +0.71%
Return On Assets -35.2 % +39.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 186M shares +1.35%
Common Stock, Shares, Outstanding 186M shares -2.93%
Entity Public Float 226M USD +107%
Common Stock, Value, Issued 19K USD 0%
Weighted Average Number of Shares Outstanding, Basic 206M shares +8.24%
Weighted Average Number of Shares Outstanding, Diluted 206M shares +8.24%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 98.4M USD +9.22%
Research and Development Expense 121M USD +5.91%
General and Administrative Expense 76.8M USD -0.86%
Costs and Expenses 204M USD -42.4%
Operating Income (Loss) -105M USD +60.1%
Nonoperating Income (Expense) -14M USD -11.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -119M USD +56.9%
Income Tax Expense (Benefit) -239K USD -19.5%
Net Income (Loss) Attributable to Parent -119M USD +56.9%
Earnings Per Share, Basic -0.58 USD/shares +60%
Earnings Per Share, Diluted -0.58 USD/shares +60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 44.3M USD +25.4%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD -100%
Other Assets, Current 6.07M USD -38%
Assets, Current 261M USD -21%
Property, Plant and Equipment, Net 3.41M USD -81.9%
Operating Lease, Right-of-Use Asset 8.41M USD -53.3%
Goodwill 0 USD -100%
Other Assets, Noncurrent 4.65M USD +0.07%
Assets 304M USD -23.7%
Accounts Payable, Current 11.6M USD +17.4%
Employee-related Liabilities, Current 2.83M USD -49%
Accrued Liabilities, Current 30M USD +35.2%
Liabilities, Current 61.4M USD +19.8%
Operating Lease, Liability, Noncurrent 82.7M USD -16.1%
Other Liabilities, Noncurrent 7.24M USD +56.2%
Liabilities 243M USD -8.96%
Accumulated Other Comprehensive Income (Loss), Net of Tax 61K USD -23.8%
Retained Earnings (Accumulated Deficit) -3.6B USD -3.42%
Stockholders' Equity Attributable to Parent 60.7M USD -53.6%
Liabilities and Equity 304M USD -23.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -47.9M USD +7.76%
Net Cash Provided by (Used in) Financing Activities 42M USD
Net Cash Provided by (Used in) Investing Activities 19.3M USD -52.6%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 194M shares +1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13.4M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 44.3M USD +25.4%
Deferred Tax Assets, Valuation Allowance 859M USD +0.53%
Deferred Tax Assets, Gross 862M USD +0.45%
Operating Lease, Liability 103M USD -12.9%
Payments to Acquire Property, Plant, and Equipment 157K USD -63.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -119M USD +55.8%
Lessee, Operating Lease, Liability, to be Paid 119M USD -15.4%
Operating Lease, Liability, Current 19.9M USD +3.16%
Lessee, Operating Lease, Liability, to be Paid, Year Two 23M USD +3.16%
Lessee, Operating Lease, Liability, to be Paid, Year One 20.5M USD +3.17%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -38K USD +97.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.3M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.7M USD +3.15%
Deferred Tax Assets, Operating Loss Carryforwards 588M USD +2.23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 136M USD +7.25%
Lessee, Operating Lease, Liability, to be Paid, Year Four 24.4M USD +3.15%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.38M USD -17.4%
Share-based Payment Arrangement, Expense 21.6M USD -35.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%